Gene · 6599
SMARCC1: SWI/SNF related BAF chromatin remodeling complex subunit C1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SMARCC1: SWI/SNF related BAF chromatin remodeling complex subunit C1. Genes, record 6599. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6599
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q92922 | SWI/SNF complex subunit SMARCC1 | 1,105 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents22
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 65986 | Q92922 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1495 | Q92922 | Espacenet |
| JP 2025164846 A | 2025-10-30 | 48 | Q92922 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1112 | Q92922 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15638 | Q92922 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1112 | Q92922 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1495 | Q92922 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15638 | Q92922 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15638 | Q92922 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15477 | Q92922 | Espacenet |
1 to 10 of 22
See all 22 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,561
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SMARCC1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 21 | 2025 |
| R01CA113794 | The function of Snf5 (SMARCB1), an epigenetic tumor suppressor | 14 | 2025 |
| R01CA163915 | ATP-Dependent Chromatin Remodeling in Human Malignancy | 12 | 2025 |
| R01CA172152 | Role of the SWI/SNF complex in tumor suppression | 12 | 2025 |
| ZIAES071006 | Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells | 11 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 10 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 7 | 2025 |
| R01CA202919 | Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer | 7 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 7 | 2025 |
1 to 10 of 1,561Source NIH's project files
See all 1,561 nih grantsPapers1,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ARID2 Loss Destabilizes PBAF and Drives Colorectal Cancer. | Mol Carcinog | 2026 | 42762512 | PubTator, text mining | PubMed |
| Smarcc1 drives optic stalk patterning and optic nerve head astrocyte differentiation. | Development | 2026 | 42592906 | PubTator, text mining | PubMed |
| Arginine methylation of BAF155 regulates interactions with RNA processing machinery. | bioRxiv | 2026 | 42239058 | PubTator, text mining | PubMed |
| G3BP1 is a SWI/SNF-bound regulator of transcription that modulates activation of STATs. | Biosci Rep | 2026 | 41952619 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| ARID1A deficiency activates OSM-STAT3 axis in endometrial cancer, creating vulnerability to JAK/STAT3 inhibition. | Int J Biol Sci | 2026 | 41800254 | PubTator, text mining | PubMed |
| Single-cell multi-omic techniques highlight the diverse composition and intercellular interactions of the vestibular schwannoma tumor microenvironment. | Neurooncol Adv | 2026 | 41769413 | PubTator, text mining | PubMed |
| Prognostic determinants and survival outcomes in epithelioid sarcoma: A contemporary population-based analysis of 1123 patients. | Medicine (Baltimore) | 2026 | 41731748 | PubTator, text mining | PubMed |
| SWI/SNF nuclear foci scaffold peripheral gene hubs for circadian chromatin control. | bioRxiv | 2026 | 41676619 | PubTator, text mining | PubMed |
| SWI/SNF Chromatin Remodelling Complex in Hepatic Physiology: Mechanistic Insights Into Development, Homeostasis and Pathogenesis. | J Cell Mol Med | 2026 | 41578412 | PubTator, text mining | PubMed |
1 to 10 of 1,611
See all 1,611 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6599
GET https://conductscience.org/api/genes/v1/6599/patents?page=2